Gene therapy for chronic spinal cord injury (AIS-A/B)
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial tests a new gene therapy called STUP-001 that aims to repair spinal cord damage directly. It is for people who have had a traumatic spinal cord injury with complete or near-complete paralysis (AIS-A or B) for at least 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 60 years old.
- You have a traumatic spinal cord injury that is classified as AIS-A (no feeling or movement below injury) or AIS-B (some feeling but no movement).
- Your injury happened at least 6 months ago.
- You are generally healthy, with no serious heart, diabetes, or blood clotting problems.
- You have not had gene or cell therapy involving AAV2 before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of stem cells injected into the spinal fluid and a non-invasive spinal cord stimulation device to see if they can improve recovery after a spinal cord injury. It is for people who have had a single traumatic injury between neck and mid-back, 1 to 5 years ago, and are in stable health.
This phase 1 trial tests a new treatment made from stem cells (XS228) for people who had a spinal cord injury 14 to 60 days ago. Doctors want to see if it's safe and if it might help with recovery.
This trial tests whether a new cell therapy (XS228) can help people with recent spinal cord injuries recover function. The cells are given through a spinal tap and are designed to replace damaged nerve cells.
This study tests a new treatment for spinal cord injury that is given through a spinal tap. It is for people with a recent or past spinal cord injury who are at least 18 years old. The treatment may help improve recovery.
This trial tests whether a stimulating device placed near the spinal cord can help improve movement and rehabilitative function in people with long-term spinal cord injuries. It may help some patients strengthen function, but only if they meet specific injury and health requirements.
This trial tests a cell transplant approach for people with a very severe spinal cord injury. It focuses first on safety and also looks for early signs the therapy may improve function.
Hear when a new Chronic Spinal Cord Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.